Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
25-OH D Vitamin in Haemodialysis Patients
NCT01457001Phase 3Terminated
- Sponsor
- Italian Society of Nephrology
- Start
- Nov 2012
- Primary completion
- Nov 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of calcifediol in chronic kidney disease (CKD) (2 arms), sponsored by Italian Society of Nephrology. Primary endpoints: Vital status at 3 years, Onset of non fatal myocardial infarction at 3 years and 1 more. Started Nov 2012; status: terminated.
02
Drugs
calcifediol
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT01457001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01457001.